Abstract
Monitoring ECMO system is important in order to avoid potentially life-threatening adverse events. Cannulae, tubing, pump, and membrane lung may break or fail due to both mechanical and patient-related complications. Moreover, membrane lung gas transfer capability should be frequently monitored to titrate ECMO therapy and to record membrane lung performance. The most common monitored parameters are power supply, pressures across the system, blood flow, rotation per minute of the pump (RPM), ABGs across ML, coagulation, and hemolysis blood tests.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Da Broi U, Adami V, Falasca E et al (2006) A new oxygenator change-out system and procedure [Internet]. Perfusion 21:297–303. Available from: http://prf.sagepub.com/cgi/doi/10.1177/0267659106074771
Schaadt J (1999) Oxygenator thrombosis: an international phenomenon. Perfusion 14:425–435
Annich GM (2012) ECMO: extracorporeal cardiopulmonary support in critical care, Red book. Extracorporeal Life Support Organization. Ann Arbor, Michigan, USA
Palanzo D, Qiu F, Baer L et al (2010) Evolution of the extracorporeal life support circuitry. Artif Organs 34:869–873
Barrett CS, Jaggers JJ, Cook EF et al (2013) Pediatric ECMO outcomes: comparison of centrifugal versus roller blood pumps using propensity score matching. ASAIO J 59:145–151
Cornelissen CG, Dietrich M, Gromann K et al (2013) Fibronectin coating of oxygenator membranes enhances endothelial cell attachment. Biomed Eng Online 12:7. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23356939&retmode=ref&cmd=prlinks
Oliver WC (2009) Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 13:154–175
Mielck F, Quintel M (2005) Extracorporeal membrane oxygenation. Curr Opin Crit Care 11(1):87–93
Muntean W (1999) Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 23:979–983
Baird CW, Zurakowski D, Robinson B et al (2007) Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival [Internet]. Ann Thorac Surg 83:912–919; discussion 919–920. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0003497506018790
Arepally GM, Ortel TL (2006) Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355:809–817
Sakr Y (2011) Heparin-induced thrombocytopenia in the ICU: an overview [Internet]. Crit Care 15:211. Available from: http://ccforum.com/series/annualupdate
Favaloro EJ, Lippi G (2011) Coagulation update: what’s new in hemostasis testing? Thromb Res 127(Suppl 2):S13–S16
De Waele JJ, Van Cauwenberghe S, Hoste EAJ et al (2003) The use of the activated clotting time for monitoring heparin therapy in critically ill patients. Intensive Care Med 29:325–328
Young G, Yonekawa KE, Nakagawa P et al (2004) Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits. Perfusion 19:283–288
Beiderlinden M, Treschan T, Görlinger K et al (2007) Argatroban in extracorporeal membrane oxygenation. Artif Organs 31:461–465
Zayac EA, Pivalizza EG, Levine RL (2008) Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban. Anesth Analg 106:351–352
Pappalardo F, Maj G, Scandroglio A et al (2009) Bioline(R) heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated [Internet]. Perfusion 24:135–137. Available from: http://prf.sagepub.com/cgi/doi/10.1177/0267659109106773
Riley RL, Cournand A (1951) Analysis of factors affecting partial pressures of oxygen and carbon dioxide in gas and blood of lungs: theory. J Appl Physiol 4:77–101
Fried DW, Zombolas TL, Leo JJ et al (1998) Clinical oxygen transfer comparison of the Terumo Capiox SX18 and SX25 membrane oxygenators. Perfusion 13:119–127
Segers PAM, Heida JF, de Vries I et al (2001) Clinical evaluation of nine hollow-fibre membrane oxygenators. Perfusion 16:95–106
Jegger D, Tevaearai HT, Mallabiabarrena I et al (2007) Comparing oxygen transfer performance between three membrane oxygenators: effect of temperature changes during cardiopulmonary bypass. Artif Organs 31:290–300
Lehle C, Philipp A, Gleich O et al (2008) Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethypentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J 54:612–617
Zhou X, Loran DB, Wang D et al (2005) Seventy-two hour gas exchange performance and hemodynamic properties of NOVALUNG®iLA as a gas exchanger for arteriovenous carbon dioxide removal. Perfusion 20:303–308
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Isgrò, S., Mojoli, F., Avalli, L. (2014). Monitoring the ECMO Patient: The Extracorporeal Circuit. In: Sangalli, F., Patroniti, N., Pesenti, A. (eds) ECMO-Extracorporeal Life Support in Adults. Springer, Milano. https://doi.org/10.1007/978-88-470-5427-1_35
Download citation
DOI: https://doi.org/10.1007/978-88-470-5427-1_35
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5426-4
Online ISBN: 978-88-470-5427-1
eBook Packages: MedicineMedicine (R0)